Total raised
$6.8M
Last: Series A 2014-02
Stage
Mature
Founded
2006
Headcount
6
HQ
Yokne'am Illit
Sector
Health Tech & Life Sciences
About
BioCEP develops, manufactures, and sells technologies for cell isolation to customers worldwide. The companys patented Cell Enrichment Process for Isolation of Rare Cells (CEPir) device enables effective immunomagnetic cell isolation for research and development. The CEPir isolates rare cells at high purity and recovery rates, offering an alternative to traditional solutions. The device is for research use only and is not intended for clinical or therapeutic use. BioCep is also currently developing applications in noninvasive prenatal testing and stem cell separation based on its technology. BioCEP is certified according to ISO 13485.
Funding history · 2 rounds · $6.8M total
2014-02
Series A
$5.3M
2013-07
Seed
$1.5M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & ScreeningIndustrial Technologies
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcareProvidersLaboratoriesLife SciencesBiotechnologyCommerce & RetailDistribution ChannelsDistributorIndustrial ManufacturingIndustrial EquipmentEducation
Business model
B2B
Highlights
1 Patents
Tags
laboratoriesmedical-technologiesbiotechnologybioprocessdiagnosticspregnancyacademianon-invasivestem-cellsindustrial-technologiesautomation